Back to MORGAN STANLEY MORGAN STANLEY

CYPHCYPH
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in LEAP THERAPEUTICS INC

MORGAN STANLEY holds 174,586 shares of CYPH (LEAP THERAPEUTICS INC), worth $106,900 as of 2026-Q2. The position was increased (+365.5% shares).

Current Value

$106,900

Current Shares

174,586

Total Value Change

+$104,807

Total Shares Change

+173,518

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
174,586
+365.5%
$106,9000.0%$0.61
24
2026-Q1
Increased
37,505
+7617.1%
$29,8010.0%$0.80
21
2025-Q4
Decreased
486
-1.6%
$5630.0%$1.16
0
2025-Q3
Decreased
494
-22.1%
$2250.0%$0.45
0
2025-Q2
Decreased
634
-47.4%
$1880.0%$0.30
0
2025-Q1
Decreased
1,205
-14.7%
$3670.0%$0.31
0
2024-Q4
Increased
1,412
+32.2%
$4,0600.0%$2.88
12
2024-Q3
Unchanged
1,068
0.0%
$2,7450.0%$2.57
0
2024-Q2
First report
1,068
-
$2,0930.0%$1.96
0

Other major holders of CYPH: BALYASNY ASSET MANAGEMENT L.P., BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used